<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1S. Hacein-Bey-Abina, Marina Cavazzana, Christof von Kalle et al.|Science|2003Cited by 3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patientsJérôme Hadjadj, Benjamin Terrier, Nader Yatim et al.|Science|2020Cited by 3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseMarina Cavazzana, Alain Fischer, Salima Hacein‐Bey et al.|Science|2000Cited by 2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencySalima Hacein‐Bey‐Abina, Alain Fischer, N. M. Wulffraat et al.|New England Journal of Medicine|2003Cited by 1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1Salima Hacein‐Bey‐Abina, Marina Cavazzana, Alexandrine Garrigue et al.|Journal of Clinical Investigation|2008Cited by 1.8k